Heart Rate Slowing by If Current Inhibition
eBook - PDF

Heart Rate Slowing by If Current Inhibition

  1. English
  2. PDF
  3. Available on iOS & Android
eBook - PDF

Heart Rate Slowing by If Current Inhibition

About this book

This book unfolds the history of the discovery of the transmembrane channel which is responsible for the 'funny' or If current, the primary modulator of heart rate. Inhibition of this current leads to slowing of the heart rate, which is an important component of the successful management of angina pectoris. Recently, Ivabradine, a specific and selective inhibitor of the If current, has been developed as an antianginal agent which has been shown to be at least as effective as both beta-blockers and calcium channel blockers for the treatment of angina. The development, efficacy and complications of this therapy are discussed in detail in this book. Furthermore, the clinical benefits from heart rate reduction in patients with coronary artery disease and heart failure and in patients after myocardial infarction are examined. Whether a lower heart rate per se will prolong life is not yet known, but it may offer a new and important life-saving strategy. The current data presented in this volume will be appreciated by cardiologists and general physicians interested in the modern management of angina pectoris and by electrophysiologists and physiologists who would like to understand the importance of heart rate and its regulation.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Heart Rate Slowing by If Current Inhibition by A. J. Camm,M. Tendera, J. S. Borer in PDF and/or ePUB format, as well as other popular books in Medicine & Pharmacology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
S. Karger
Year
2006
Print ISBN
9783805581608
eBook ISBN
9783318013818
Edition
1
Subtopic
Pharmacology

Table of contents

  1. Cover
  2. Contents
  3. Foreword
  4. Heart Rate: A Risk Factor for Cardiac Diseases and Outcomes?
  5. If Current Inhibition: Cellular Basis and Physiology
  6. Heart Rate Reduction by Pharmacological If Current Inhibition
  7. Clinical Perspectives of Heart Rate Slowing for Coronary Event Reduction and Heart Failure
  8. Clinical Effect of ‘Pure’ Heart Rate Slowing with a Prototype If Current Inhibitor: Placebo-Controlled Experience with Ivabradine
  9. Heart Rate Slowing versus Other Pharmacological Antianginal Strategies
  10. Novel If Current Inhibitor Ivabradine: Safety Considerations
  11. Heart Rate Slowing for Myocardial Dysfunction/Heart Failure
  12. Future Directions:What Data Do We Need?
  13. Author Index
  14. Subject Index